| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Chief Financial Officer | Employee Stock Option (right to buy) | 41,899 | 01 Apr 2025 | Direct | ||
| ACTUATE THERAPEUTICS, INC. | Chief Financial Officer | Non-Qualified Stock Options | 0 | 14 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACTU | ACTUATE THERAPEUTICS, INC. | 01 Apr 2025 | 2 | $0 | 4 | Chief Financial Officer | 02 Apr 2025, 13:41 |
| ACTU | ACTUATE THERAPEUTICS, INC. | 14 Aug 2024 | 1 | $0 | 4 | Chief Financial Officer | 14 Aug 2024, 19:28 |
| ACTU | ACTUATE THERAPEUTICS, INC. | 12 Aug 2024 | 0 | $0 | 3 | Chief Financial Officer | 12 Aug 2024, 21:46 |